192 related articles for article (PubMed ID: 9425421)
21. [Study of color perception using a new color test and desaturated panel D 15 in normal subjects and diabetics].
Mecca E; Tovena G; Marchini G; Manganotti A; Marraffa M; Bonomi L
J Fr Ophtalmol; 1988; 11(6-7):493-500. PubMed ID: 3209812
[TBL] [Abstract][Full Text] [Related]
22. Chromatic contrast thresholds as a prognostic test for visual improvement after macular hole surgery: color vision and macular hole surgery outcome.
Poon WK; Ong GL; Ripley LG; Casswell AG
Retina; 2001; 21(6):619-26. PubMed ID: 11756885
[TBL] [Abstract][Full Text] [Related]
23. Quantitative phenotyping of chromatic dysfunction in best macular dystrophy.
Campos SH; Forjaz V; Kozak LR; Silva E; Castelo-Branco M
Arch Ophthalmol; 2005 Jul; 123(7):944-9. PubMed ID: 16009836
[TBL] [Abstract][Full Text] [Related]
24. [The role of color vision disturbances in diagnostics of early diabetic retinopathy].
Mulak M; Reniewska B; Kostuś E; Balcewicz A; Misiuk-Hojło M
Klin Oczna; 2002; 104(3-4):249-51. PubMed ID: 12608311
[TBL] [Abstract][Full Text] [Related]
25. Automated tritan discrimination sensitivity: a new clinical technique for the effective screening of severe diabetic retinopathy.
Tregear SJ; Ripley LG; Knowles PJ; Gilday RT; de Alwis DV; Reffin JP
Int J Psychophysiol; 1994 May; 16(2-3):191-8. PubMed ID: 8089038
[TBL] [Abstract][Full Text] [Related]
26. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.
Browning DJ; Fraser CM; Clark S
Ophthalmology; 2008 Mar; 115(3):533-539.e2. PubMed ID: 18067962
[TBL] [Abstract][Full Text] [Related]
27. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
Birch J; Dain SJ
Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
[TBL] [Abstract][Full Text] [Related]
28. Acquired 'tritan' deficiencies in macular pathology.
Moreland JD; Maione M; Carta F; Scoccianti L
Mod Probl Ophthalmol; 1978; 19():270-5. PubMed ID: 310044
[TBL] [Abstract][Full Text] [Related]
29. [Diabetes and color vision disorder detected by the Farnsworth 100 Hue test. Diabetic dyschromatopsia].
Ayed S; Jeddi A; Kallal Z
J Fr Ophtalmol; 1990; 13(10):506-10. PubMed ID: 2081841
[TBL] [Abstract][Full Text] [Related]
30. The Macular Assessment Profile test - a new VDU-based technique for measuring the spatial distribution of the macular pigment, lens density and rapid flicker sensitivity.
Barbur JL; Konstantakopoulou E; Rodriguez-Carmona M; Harlow JA; Robson AG; Moreland JD
Ophthalmic Physiol Opt; 2010 Sep; 30(5):470-83. PubMed ID: 20883330
[TBL] [Abstract][Full Text] [Related]
31. A new colour vision arrangement test to detect functional changes in diabetic macular oedema.
Maár N; Tittl M; Stur M; Zajic B; Reitner A
Br J Ophthalmol; 2001 Jan; 85(1):47-51. PubMed ID: 11133711
[TBL] [Abstract][Full Text] [Related]
32. Blue-yellow vision deficits in patients with diabetes.
Rockett M; Anderle D; Bessman AN
West J Med; 1987 Apr; 146(4):431-3. PubMed ID: 3495070
[TBL] [Abstract][Full Text] [Related]
33. Silent substitution S-cone electroretinogram in subjects with diabetes mellitus.
Mortlock KE; Chiti Z; Drasdo N; Owens DR; North RV
Ophthalmic Physiol Opt; 2005 Sep; 25(5):392-9. PubMed ID: 16101944
[TBL] [Abstract][Full Text] [Related]
34. Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
Pföhler C; Tschöp S; König J; Rass K; Tilgen W
Melanoma Res; 2006 Oct; 16(5):413-21. PubMed ID: 17013090
[TBL] [Abstract][Full Text] [Related]
35. Evidence for mild blue-yellow colour vision deficits immediately following fluorescein angiography.
Sankeralli MJ; Chen JC; Metha AB; Mullen KT
Ophthalmic Physiol Opt; 2000 Mar; 20(2):137-41. PubMed ID: 10829137
[TBL] [Abstract][Full Text] [Related]
36. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
[TBL] [Abstract][Full Text] [Related]
37. [Changes in the colour vision and contrast sensitivity in diabetic patients without retinopathy].
Malukiewicz G; Lesiewska-Junk H; Kaźmierczak K
Klin Oczna; 2009; 111(7-9):221-3. PubMed ID: 19899578
[TBL] [Abstract][Full Text] [Related]
38. [A multifactorial etiologic approach to diabetic dyschromatopsia. Study of 100 diabetics].
Doucet J; Retout A; Poutrain JR; Ozenne G; Leprince MP; Parain D; Brasseur G; Schrub JC
Diabete Metab; 1991; 17(1):31-7. PubMed ID: 1868958
[TBL] [Abstract][Full Text] [Related]
39. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
Flanagan P; Zele AJ
Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
[TBL] [Abstract][Full Text] [Related]
40. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.
Utku D; Atmaca LS
Ann Ophthalmol; 1992 Jun; 24(6):205-8. PubMed ID: 1444079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
